This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Elanco US, Inc.
Elanco US, Inc., a leading global animal health company, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1954, Elanco has established itself as a key player in the animal health industry, focusing on innovative solutions for both livestock and companion animals. The company offers a diverse range of products and services, including vaccines, parasiticides, and nutritional supplements, all designed to enhance animal health and productivity. Elanco's commitment to research and development has led to significant advancements in animal care, positioning it as a trusted partner for veterinarians and farmers alike. With a strong market presence and a reputation for quality, Elanco continues to achieve notable milestones, reinforcing its status as a pioneer in the animal health sector.
DitchCarbon Score
How does Elanco US, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elanco US, Inc.'s score of 57 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Elanco US, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of Elanco Animal Health Incorporated, which may influence its climate commitments and emissions reporting. While no specific reduction targets or achievements are listed for Elanco US, Inc., it is important to note that the broader corporate family, Elanco Animal Health Incorporated, may have established initiatives and targets related to carbon emissions reduction. However, details on these initiatives, including any Science-Based Targets Initiative (SBTi) commitments or other climate pledges, are not provided in the available data. As a subsidiary, Elanco US, Inc. may align its climate strategies with those of its parent company, which could include industry-standard practices for managing and reducing greenhouse gas emissions across various scopes. Without specific emissions data or reduction targets, the company's current climate commitments remain unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 274,550,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 418,271,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Elanco US, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
